Management of Severe Asthma in the Emergency Room
Immediately administer high-flow oxygen (40-60% via face mask or reservoir mask at 15 L/min if SpO₂ <85%), nebulized salbutamol 5 mg (or terbutaline 10 mg) via oxygen-driven nebulizer, and systemic corticosteroids (prednisolone 30-60 mg orally OR IV hydrocortisone 200 mg) within the first few minutes of arrival. 1, 2
Initial Assessment and Recognition
Upon arrival, rapidly assess for features of severe or life-threatening asthma:
- Cannot complete sentences in one breath
- Respiratory rate >25 breaths/min
- Heart rate >110 beats/min
- Peak expiratory flow (PEF) <50% of predicted or personal best
Life-threatening features: 3, 2
- Silent chest, cyanosis, or feeble respiratory effort
- Bradycardia or hypotension
- Exhaustion, confusion, altered consciousness, or coma
- SpO₂ <92%
First-Line Treatment Protocol (First Hour)
Step 1: Oxygen Therapy
- Target SpO₂ >90% (>95% in pregnant patients or those with heart disease) 1, 2
- Use high-flow oxygen 40-60% via face mask or reservoir mask at 15 L/min if initial SpO₂ <85% 3, 2
- Continue oxygen monitoring until clear response to bronchodilator therapy occurs 1
Step 2: Nebulized Beta-Agonists
- Administer salbutamol 5 mg OR terbutaline 10 mg via oxygen-driven nebulizer 3, 1
- Repeat every 20 minutes for 3 doses in the first hour 1, 2
- If no nebulizer available, give 2 puffs via large volume spacer and repeat (up to 20 puffs maximum) 3
Step 3: Systemic Corticosteroids (Administer Immediately)
- Give prednisolone 30-60 mg orally OR IV hydrocortisone 200 mg 3, 1
- Critical point: Corticosteroids take 6-12 hours to show clinical effect, so early administration is essential 1, 4
- Continue high-dose steroids: prednisolone 30-60 mg daily OR IV hydrocortisone 200 mg every 6 hours 1
Step 4: Add Ipratropium for Severe Cases
- Add ipratropium bromide 0.5 mg to nebulized beta-agonist for severe exacerbations or inadequate response to initial therapy 1, 5, 6
- Can be mixed in the nebulizer with albuterol if used within one hour 7
Reassessment at 15-30 Minutes
Measure PEF or FEV₁, assess symptoms, vital signs, and oxygen saturation 1:
If PEF >75% predicted: 3
- Step up usual treatment
- Consider discharge with close follow-up
If PEF 50-75% predicted: 3
- Repeat nebulized beta-agonist
- Give prednisolone 40 mg if not already administered
- Wait 30 minutes and reassess
If PEF <50% predicted or severe features persist: 3
- Arrange hospital admission
- Continue intensive treatment
Additional Interventions for Life-Threatening or Refractory Cases
Intravenous Magnesium Sulfate
- Give IV magnesium sulfate 2g over 20 minutes for severe exacerbations unresponsive to initial treatment 8, 5, 6
Parenteral Beta-Agonists or Aminophylline
- Consider IV aminophylline 250 mg over 20 minutes OR subcutaneous terbutaline 250 µg for life-threatening exacerbations 3, 1
- Caution: Use aminophylline with extreme caution if patient already taking theophyllines 3
Arterial Blood Gas Monitoring
- Repeat arterial blood gases within 2 hours if initial PaO₂ <8 kPa or if PaCO₂ was normal/elevated 2
Critical Pitfalls to Avoid
Absolutely contraindicated: 1
- Sedatives of any kind—never administer in acute asthma
- Antibiotics unless bacterial infection (pneumonia/sinusitis) is confirmed
Avoid treatments lacking evidence: 8
- Aggressive hydration or large volumes of liquids
- Mucolytics
- Chest physiotherapy
- Over-the-counter antihistamines or cold remedies
Criteria for Hospital Admission
Admit if any of the following persist after initial treatment: 3, 1, 2
- Any life-threatening features present
- PEF <33% predicted after treatment
- Features of severe attack persist after 1-2 hours of intensive treatment
- PEF <50% predicted with inadequate response
Criteria for ICU Transfer
Transfer immediately if: 2
- Deteriorating PEF despite treatment
- Worsening or persisting hypoxia
- Hypercapnia
- Exhaustion, confusion, drowsiness, or altered mental status
- Patient unconscious or confused—call ICU/anesthesia immediately and do not attempt intubation until most expert available doctor is present 3
Monitoring During Treatment
- Measure and record PEF 15-30 minutes after starting treatment, then according to response 1
- Monitor oxygen saturation continuously until clear response occurs 1, 8
- Assess for signs of clinical deterioration requiring escalation of care 2
Special Considerations
High-risk patients requiring extra vigilance: 3
- Previous ICU admissions or intubations
- Recent hospitalizations or frequent ED visits
- Poor perception of airflow obstruction severity
- History of sudden severe (brittle) asthma
Stay with the patient until ambulance arrives if arranging transfer 3